Recombinant multi-species UXT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UXT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene functions as a cofactor that modulates androgen receptor-dependent transcription, and also plays a critical role in tumor necrosis factor-induced apoptosis. Expression of this gene may play a role in tumorigenesis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
The Alternative Names of target: 0910002B17Rik,ART-27,Androgen receptor trapped clone 27 protein (ART-27),Protein UXT,SKP2,STAP1,UXT,Ubiquitously expressed transcript protein,Uxt

Target products collectionGo to UXT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12803-Ag-1/ GM-Tg-hg-IP12803-Ag-2 Human UXT protein Human
GM-Tg-rg-IP12803-Ag-1/ GM-Tg-rg-IP12803-Ag-2 Rat UXT protein Rat
GM-Tg-mg-IP12803-Ag-1/ GM-Tg-mg-IP12803-Ag-2 Mouse UXT protein Mouse
GM-Tg-cynog-IP12803-Ag-1/ GM-Tg-cynog-IP12803-Ag-2 Cynomolgus/Rhesus macaque UXT protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12803-Ag-1/ GM-Tg-felg-IP12803-Ag-2 Feline UXT protein Feline
GM-Tg-cang-IP12803-Ag-1/ GM-Tg-cang-IP12803-Ag-2 Canine UXT protein Canine
GM-Tg-bovg-IP12803-Ag-1/ GM-Tg-bovg-IP12803-Ag-2 Bovine UXT protein Bovine
GM-Tg-equg-IP12803-Ag-1/ GM-Tg-equg-IP12803-Ag-2 Equine UXT protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12803-Ag-1/ GM-Tg-hg-IP12803-Ag-2; GM-Tg-rg-IP12803-Ag-1/ GM-Tg-rg-IP12803-Ag-2;
GM-Tg-mg-IP12803-Ag-1/ GM-Tg-mg-IP12803-Ag-2; GM-Tg-cynog-IP12803-Ag-1/ GM-Tg-cynog-IP12803-Ag-2;
GM-Tg-felg-IP12803-Ag-1/ GM-Tg-felg-IP12803-Ag-2; GM-Tg-cang-IP12803-Ag-1/ GM-Tg-cang-IP12803-Ag-2;
GM-Tg-bovg-IP12803-Ag-1/ GM-Tg-bovg-IP12803-Ag-2; GM-Tg-equg-IP12803-Ag-1/ GM-Tg-equg-IP12803-Ag-2
Products Name UXT protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name UXT
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UXT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.